Evaluation of the use of benzodiazepines in an elderly population in the interior of Bahia
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Debates em Psiquiatria (Online) |
Texto Completo: | https://revistardp.org.br/revista/article/view/482 |
Resumo: | Introduction: The elderly population is more vulnerable to the adverse effects of benzodiazepines due to higher risk of having multiple comorbidities, polypharmacy and drug interactions. Objective: To evaluate the prescription of benzodiazepines in the elderly population in a Health Center in the interior of Bahia. Methods: This is a descriptive, retrospective, observational and cross-sectional study, which included elderly patients over 60 years old. A selection of the patient population from the clinic was carried out, meeting the inclusion and exclusion criteria, an epidemiological survey through a only one structured interview and Mini Mental State Examination to assess their cognition. Data was analyzed using the Statistical Package for Social Sciences software (SPSS Inc., Chicago, IL, USA), version 14.0, and the variables were expressed in frequency and percentages and, for comparison between them, the Test of the Chi Square was utilized. Finally, p value≤0.05 was established to demonstrate statistical significance. Results: The rate of benzodiazepines use in this population was 65%, with a predominance of clonazepam (39.1%) and diazepam (29.7%). The specialists who most prescribed benzodiazepines were psychiatrists (53.9%) followed by practitioners (32%). Among the elderly who use benzodiazepines, 41.4% were instructed to make a discontinuation attempt, and of these, 35.8% managed to complete the request. Among those who tried and were unsuccessful, the main causes of failure were abrupt stop of the medication (44.1%) and recurrence of symptoms during gradual tapering off process (32.4%). Conclusions: The study demonstrated a high prevalence of benzodiazepine use in the elderly in this sample, with low incentive to discontinue these medications, tending to its abuse with aging. Therefore, strategies to discontinue benzodiazepines should be encouraged, as well as the training of the entire team in dealing with this public health issue. |
id |
ABP-2_18736a5d8d0b48a79787a246b4a008f4 |
---|---|
oai_identifier_str |
oai:ojs.emnuvens.com.br:article/482 |
network_acronym_str |
ABP-2 |
network_name_str |
Debates em Psiquiatria (Online) |
repository_id_str |
|
spelling |
Evaluation of the use of benzodiazepines in an elderly population in the interior of BahiaEvaluación del uso de benzodiazepinas en una población anciana del interior de BahiaAvaliação do uso de benzodiazepínicos em população idosa no interior da BahiabenzodiazepínicosprevalênciaidososbenzodiazepinasprevalenciaancianosbenzodiazepinesprevalenceelderlyIntroduction: The elderly population is more vulnerable to the adverse effects of benzodiazepines due to higher risk of having multiple comorbidities, polypharmacy and drug interactions. Objective: To evaluate the prescription of benzodiazepines in the elderly population in a Health Center in the interior of Bahia. Methods: This is a descriptive, retrospective, observational and cross-sectional study, which included elderly patients over 60 years old. A selection of the patient population from the clinic was carried out, meeting the inclusion and exclusion criteria, an epidemiological survey through a only one structured interview and Mini Mental State Examination to assess their cognition. Data was analyzed using the Statistical Package for Social Sciences software (SPSS Inc., Chicago, IL, USA), version 14.0, and the variables were expressed in frequency and percentages and, for comparison between them, the Test of the Chi Square was utilized. Finally, p value≤0.05 was established to demonstrate statistical significance. Results: The rate of benzodiazepines use in this population was 65%, with a predominance of clonazepam (39.1%) and diazepam (29.7%). The specialists who most prescribed benzodiazepines were psychiatrists (53.9%) followed by practitioners (32%). Among the elderly who use benzodiazepines, 41.4% were instructed to make a discontinuation attempt, and of these, 35.8% managed to complete the request. Among those who tried and were unsuccessful, the main causes of failure were abrupt stop of the medication (44.1%) and recurrence of symptoms during gradual tapering off process (32.4%). Conclusions: The study demonstrated a high prevalence of benzodiazepine use in the elderly in this sample, with low incentive to discontinue these medications, tending to its abuse with aging. Therefore, strategies to discontinue benzodiazepines should be encouraged, as well as the training of the entire team in dealing with this public health issue.Introducción: Los adultos mayores son más vulnerables a los efectos adversos de las benzodiazepinas debido a comorbilidades, polifarmacia e interacciones medicamentosas. Objetivo: Evaluar la prescripción de benzodiazepinas en la población anciana en un Centro de Salud del interior de Bahia. Métodos: Se trata de un estudio observacional descriptivo, transversal y retrospectivo, que incluyó ancianos mayores de 60 años. Se realizó una selección de la población de pacientes del Centro de Salud cumpliendo los criterios de inclusión y exclusión, se realizó una encuesta epidemiológica a través de una entrevista estructurada en un solo momento y el Mini Examen del Estado Mental (Mini Mental State Examination) para evaluar el nivel cognitivo de los pacientes. Los datos fueron analizados mediante el software Statistical Package for Social Sciences (SPSS Inc., Chicago, IL, EE. UU.), versión 14.0, y las variables fueron expresadas en frecuencia y porcentajes y, para comparación entre ellos, la Prueba de Chi Cuadrado y p ≤0.05 valor establecido para demostrar significación estadística. Resultados: La tasa de uso de benzodiazepinas en esta población fue del 65%, con predominio de clonazepam (39,1%) y diazepam (29,7%). Los especialistas que más prescribieron benzodiacepinas fueron psiquiatras (53,9%) y médicos generales (32%). Entre los ancianos que usan benzodiazepinas, 41,4% fueron instruidos para hacer un intento de suspensión, y de estos, 35,8% lograron completar la suspensión completa. Entre los que intentaron y no tuvieron éxito, las principales causas de fracaso fueron la retirada brusca (44,1%) y la recurrencia de los síntomas durante la retirada gradual (32,4%). Conclusiones: El estudio demostró una alta prevalencia de uso de benzodiacepinas en los ancianos de esta muestra, el bajo incentivo para suspender estos medicamentos, tendiendo al abuso con el envejecimiento. Por lo tanto, se deben fomentar estrategias para suspender las benzodiazepinas, así como la capacitación de todo el equipo en el abordaje de este problema de salud pública.Introdução: Os idosos são mais vulneráveis aos efeitos adversos dos benzodiazepínicos devido comorbidades, polifarmácia e interações medicamentosas. Objetivo: Avaliar a prescrição de benzodiazepínicos na população idosa em um Centro de Saúde no interior da Bahia. Métodos: Trata-se de um estudo descritivo observacional, transversal e retrospectivo, que incluiu idosos acima de 60 anos. Foi realizada uma seleção da população de pacientes do Centro de Saude, atendendo critérios de inclusão e exclusão, um levantamento epidemiológico através de uma entrevista estruturada em um único momento e o Mini Exame do Estado Mental (Mini Mental State Examination) para avaliar nível cognitivo dos pacientes. Os dados foram analisados utilizando o software Statistical Package for Social Sciences (SPSS Inc., Chicago, IL, EUA), versão 14.0, sendo que as variáveis foram expressas em frequência e percentuais e, para comparação entre as mesmas, foi utilizado o Teste do Qui Quadrado e estabelecido valor de p≤0,05 para demonstrar significância estatística. Resultados: A taxa de uso de benzodiazepínicos nesta população foi de 65%, com predominância do clonazepam (39,1%) e diazepam (29,7%). Os especialistas que mais prescreveram os benzodiazepínicos foram psiquiatras (53,9%) e médicos generalistas (32%). Dentre os idosos que utilizam benzodiazepínicos, 41,4% foram orientados a fazer uma tentativa de descontinuação, e destes, 35,8% conseguiram realizar retirada completa. Dentre aqueles que tentaram e não obtiveram sucesso, as principais causas de falha foram a retirada abrupta (44,1%) e recorrência dos sintomas durante a retirada gradual (32,4%). Conclusões: O estudo demonstrou alta prevalência de uso de benzodiazepínicos em idosos nesta amostra, o baixo estímulo à prática de descontinuação desses medicamentos, tendendo ao abuso com o envelhecimento. Diante disso, estratégias de descontinuação dos benzodiazepínicos devem ser estimuladas assim como o treinamento de toda a equipe no enfrentamento deste problema de saúde pública.Associação Brasileira de Psiquiatria2023-05-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-ReviewedRevisado por ParesAvaliado Pelos Paresapplication/pdfhttps://revistardp.org.br/revista/article/view/48210.25118/2763-9037.2023.v13.482Debates in Psychiatry; Vol. 13 (2023); 1-20Debates em Psiquiatria; Vol. 13 (2023); 1-20Debates em Psiquiatria; v. 13 (2023); 1-202763-90372236-918Xreponame:Debates em Psiquiatria (Online)instname:Associação Brasileira de Psiquiatria (ABP)instacron:ABPporhttps://revistardp.org.br/revista/article/view/482/567Copyright (c) 2023 Jefferson Meira Pireshttps://creativecommons.org/licenses/by-nc/4.0info:eu-repo/semantics/openAccessPires, Jefferson Meira2024-01-21T09:29:04Zoai:ojs.emnuvens.com.br:article/482Revistahttps://revistardp.org.br/revista/oaiPUBhttps://revistardp.org.br/revista/oairdp@abp.org.br2763-90372236-918Xopendoar:2024-01-21T09:29:04Debates em Psiquiatria (Online) - Associação Brasileira de Psiquiatria (ABP)false |
dc.title.none.fl_str_mv |
Evaluation of the use of benzodiazepines in an elderly population in the interior of Bahia Evaluación del uso de benzodiazepinas en una población anciana del interior de Bahia Avaliação do uso de benzodiazepínicos em população idosa no interior da Bahia |
title |
Evaluation of the use of benzodiazepines in an elderly population in the interior of Bahia |
spellingShingle |
Evaluation of the use of benzodiazepines in an elderly population in the interior of Bahia Pires, Jefferson Meira benzodiazepínicos prevalência idosos benzodiazepinas prevalencia ancianos benzodiazepines prevalence elderly |
title_short |
Evaluation of the use of benzodiazepines in an elderly population in the interior of Bahia |
title_full |
Evaluation of the use of benzodiazepines in an elderly population in the interior of Bahia |
title_fullStr |
Evaluation of the use of benzodiazepines in an elderly population in the interior of Bahia |
title_full_unstemmed |
Evaluation of the use of benzodiazepines in an elderly population in the interior of Bahia |
title_sort |
Evaluation of the use of benzodiazepines in an elderly population in the interior of Bahia |
author |
Pires, Jefferson Meira |
author_facet |
Pires, Jefferson Meira |
author_role |
author |
dc.contributor.author.fl_str_mv |
Pires, Jefferson Meira |
dc.subject.por.fl_str_mv |
benzodiazepínicos prevalência idosos benzodiazepinas prevalencia ancianos benzodiazepines prevalence elderly |
topic |
benzodiazepínicos prevalência idosos benzodiazepinas prevalencia ancianos benzodiazepines prevalence elderly |
description |
Introduction: The elderly population is more vulnerable to the adverse effects of benzodiazepines due to higher risk of having multiple comorbidities, polypharmacy and drug interactions. Objective: To evaluate the prescription of benzodiazepines in the elderly population in a Health Center in the interior of Bahia. Methods: This is a descriptive, retrospective, observational and cross-sectional study, which included elderly patients over 60 years old. A selection of the patient population from the clinic was carried out, meeting the inclusion and exclusion criteria, an epidemiological survey through a only one structured interview and Mini Mental State Examination to assess their cognition. Data was analyzed using the Statistical Package for Social Sciences software (SPSS Inc., Chicago, IL, USA), version 14.0, and the variables were expressed in frequency and percentages and, for comparison between them, the Test of the Chi Square was utilized. Finally, p value≤0.05 was established to demonstrate statistical significance. Results: The rate of benzodiazepines use in this population was 65%, with a predominance of clonazepam (39.1%) and diazepam (29.7%). The specialists who most prescribed benzodiazepines were psychiatrists (53.9%) followed by practitioners (32%). Among the elderly who use benzodiazepines, 41.4% were instructed to make a discontinuation attempt, and of these, 35.8% managed to complete the request. Among those who tried and were unsuccessful, the main causes of failure were abrupt stop of the medication (44.1%) and recurrence of symptoms during gradual tapering off process (32.4%). Conclusions: The study demonstrated a high prevalence of benzodiazepine use in the elderly in this sample, with low incentive to discontinue these medications, tending to its abuse with aging. Therefore, strategies to discontinue benzodiazepines should be encouraged, as well as the training of the entire team in dealing with this public health issue. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-05-05 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer-Reviewed Revisado por Pares Avaliado Pelos Pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://revistardp.org.br/revista/article/view/482 10.25118/2763-9037.2023.v13.482 |
url |
https://revistardp.org.br/revista/article/view/482 |
identifier_str_mv |
10.25118/2763-9037.2023.v13.482 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://revistardp.org.br/revista/article/view/482/567 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2023 Jefferson Meira Pires https://creativecommons.org/licenses/by-nc/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2023 Jefferson Meira Pires https://creativecommons.org/licenses/by-nc/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Associação Brasileira de Psiquiatria |
publisher.none.fl_str_mv |
Associação Brasileira de Psiquiatria |
dc.source.none.fl_str_mv |
Debates in Psychiatry; Vol. 13 (2023); 1-20 Debates em Psiquiatria; Vol. 13 (2023); 1-20 Debates em Psiquiatria; v. 13 (2023); 1-20 2763-9037 2236-918X reponame:Debates em Psiquiatria (Online) instname:Associação Brasileira de Psiquiatria (ABP) instacron:ABP |
instname_str |
Associação Brasileira de Psiquiatria (ABP) |
instacron_str |
ABP |
institution |
ABP |
reponame_str |
Debates em Psiquiatria (Online) |
collection |
Debates em Psiquiatria (Online) |
repository.name.fl_str_mv |
Debates em Psiquiatria (Online) - Associação Brasileira de Psiquiatria (ABP) |
repository.mail.fl_str_mv |
rdp@abp.org.br |
_version_ |
1796798366057758720 |